A

ASND

Ascendis Pharma A/S
HealthcareBiotechnology|NASDAQ Global Select|DK

Price

$229.25

Market Cap

$14.07B

Beta

0.48

P/E

0.0

Div Yield

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+97.40%
EPS Growth (YoY)+39.76%
Revenue CAGR 3Y+141.17%
P/E Ratio0.0
PEG Ratio
FCF Yield+0.30%
Debt / Equity0.00
Interest Coverage-0.9x

Sign up free to unlock full analysis

  • Full 24-factor quality scorecard
  • AI investment committee analysis
  • Factor radar & value trap detection
  • 10-year strategy backtesting
  • Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for ASND.

ASND — Ascendis Pharma A/S Stock Analysis | Tessera Alpha